Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15331324rdf:typepubmed:Citationlld:pubmed
pubmed-article:15331324lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:15331324lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:15331324lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:15331324lifeskim:mentionsumls-concept:C1819439lld:lifeskim
pubmed-article:15331324lifeskim:mentionsumls-concept:C1305923lld:lifeskim
pubmed-article:15331324pubmed:issue1lld:pubmed
pubmed-article:15331324pubmed:dateCreated2004-8-27lld:pubmed
pubmed-article:15331324pubmed:abstractTextMycobacterium leprae lipoprotein, LpK, induced IL-12 production from human monocytes. To determine the components essential for cytokine production and the relative role of lipidation in the activation process, we produced lipidated and non-lipidated truncated forms of LpK. While 0.5nM of lipidated LpK-a having N-terminal 60 amino acids of LpK produced more than 700pg/ml IL-12 p40, the non-lipidated LpK-b having the same amino acids as that of LpK-a required more than 20nM of the protein to produce an equivalent dose of cytokine. Truncated protein having the C-terminal 192 amino acids of LpK did not induce any cytokine production. Fifty nanomolar of the synthetic lipopeptide of LpK produced only about 200pg/ml IL-12. Among the truncated LpK, only LpK-a and lipopeptide stimulated NF-kB-dependent reporter activity in TLR-2 transfectant. However, when monocytes were stimulated with lipopeptide in the presence of non-lipidated protein, they produced IL-12 synergistically. Therefore, both peptide regions of LpK and lipid residues are necessary for efficient IL-12 production.lld:pubmed
pubmed-article:15331324pubmed:languageenglld:pubmed
pubmed-article:15331324pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:citationSubsetIMlld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331324pubmed:statusMEDLINElld:pubmed
pubmed-article:15331324pubmed:monthMaylld:pubmed
pubmed-article:15331324pubmed:issn0008-8749lld:pubmed
pubmed-article:15331324pubmed:authorpubmed-author:MakinoMasahik...lld:pubmed
pubmed-article:15331324pubmed:authorpubmed-author:BrennanPatric...lld:pubmed
pubmed-article:15331324pubmed:authorpubmed-author:TakeshitaFumi...lld:pubmed
pubmed-article:15331324pubmed:authorpubmed-author:MaedaYumiYlld:pubmed
pubmed-article:15331324pubmed:authorpubmed-author:YamashitaYasu...lld:pubmed
pubmed-article:15331324pubmed:issnTypePrintlld:pubmed
pubmed-article:15331324pubmed:volume229lld:pubmed
pubmed-article:15331324pubmed:ownerNLMlld:pubmed
pubmed-article:15331324pubmed:authorsCompleteYlld:pubmed
pubmed-article:15331324pubmed:pagination13-20lld:pubmed
pubmed-article:15331324pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:meshHeadingpubmed-meshheading:15331324...lld:pubmed
pubmed-article:15331324pubmed:year2004lld:pubmed
pubmed-article:15331324pubmed:articleTitleRole of the polypeptide region of a 33kDa mycobacterial lipoprotein for efficient IL-12 production.lld:pubmed
pubmed-article:15331324pubmed:affiliationDepartment of Microbiology, Leprosy Research Center,National Institute of Infectious Diseases, 4-2-1 Aobacho,Higashimurayama, Tokyo 189-0002, Japan.lld:pubmed
pubmed-article:15331324pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15331324pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15331324lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15331324lld:pubmed